Legend Biotech (LEGN) has released an update. Legend Biotech’s CARVYKTI therapy, featured at the American Society of Hematology meeting, shows promising results in increasing minimal residual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback